Haplo, we have a problem

Christopher S. Hourigan

doi:10.1182/blood-2017-07-795062

Haplo, we have a problem

Christopher S. Hourigan

Research output: Contribution to journal › Comment/debate › peer-review

Abstract

In this issue of Blood, Ahci and colleagues describe a simple and robust method for identifying the phenomenon of leukemic HLA loss often associated with treatment failure of hematopoietic stem cell transplantation from haploidentical donors (haplo-HSCT).¹

Original language	English (US)
Pages (from-to)	1180
Number of pages	1
Journal	Blood
Volume	130
Issue number	10
DOIs	https://doi.org/10.1182/blood-2017-07-795062
State	Published - Sep 7 2017
Externally published	Yes

ASJC Scopus subject areas

Biochemistry
Immunology
Hematology
Cell Biology

Access to Document

10.1182/blood-2017-07-795062

Cite this

@article{58c7e35ff2014dbc801b6ee6ece0b325,

title = "Haplo, we have a problem",

abstract = "In this issue of Blood, Ahci and colleagues describe a simple and robust method for identifying the phenomenon of leukemic HLA loss often associated with treatment failure of hematopoietic stem cell transplantation from haploidentical donors (haplo-HSCT).1",

author = "Hourigan, {Christopher S.}",

note = "Funding Information: Conflict-of-interest disclosure: C.S.H. reports that his laboratory receives research funding from Merck Sharp & Dohme and SELLAS Life Sciences Group AG. n Publisher Copyright: {\textcopyright} 2017, American Society of Hematology. All rights reserved.",

year = "2017",

month = sep,

day = "7",

doi = "10.1182/blood-2017-07-795062",

language = "English (US)",

volume = "130",

pages = "1180",

journal = "Blood",

issn = "0006-4971",

publisher = "American Society of Hematology",

number = "10",

}

TY - JOUR

T1 - Haplo, we have a problem

AU - Hourigan, Christopher S.

N1 - Funding Information: Conflict-of-interest disclosure: C.S.H. reports that his laboratory receives research funding from Merck Sharp & Dohme and SELLAS Life Sciences Group AG. n Publisher Copyright: © 2017, American Society of Hematology. All rights reserved.

PY - 2017/9/7

Y1 - 2017/9/7

N2 - In this issue of Blood, Ahci and colleagues describe a simple and robust method for identifying the phenomenon of leukemic HLA loss often associated with treatment failure of hematopoietic stem cell transplantation from haploidentical donors (haplo-HSCT).1

AB - In this issue of Blood, Ahci and colleagues describe a simple and robust method for identifying the phenomenon of leukemic HLA loss often associated with treatment failure of hematopoietic stem cell transplantation from haploidentical donors (haplo-HSCT).1

UR - http://www.scopus.com/inward/record.url?scp=85029221430&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85029221430&partnerID=8YFLogxK

U2 - 10.1182/blood-2017-07-795062

DO - 10.1182/blood-2017-07-795062

M3 - Comment/debate

C2 - 28882835

AN - SCOPUS:85029221430

SN - 0006-4971

VL - 130

SP - 1180

JO - Blood

JF - Blood

IS - 10

ER -

Haplo, we have a problem

Abstract

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this